Abstract
Background: Common childhood neuropsychiatric disorders are treated with multiple categories of psycho-active agents. Adverse side effects of psychotropic pharmacotherapeutics range from expected neuro-psychiatric changes to allergic reactions and immunologic abnormalities.
Objective: This review focuses on the immune system effects of common categories of medications used to treat neuro-psychiatric and behavioral disorders.
Method: Narrative review of literature using PubMed database up to May 10, 2017.
Results: Multiple neuro- and psycho-tropic medication classes are found to influence the function of the immune system in various ways, both in the direction of immune suppression and immune stimulation.
Conclusion: Immunologic activity of these medications in the frame-work of now wellestablished role of inflammation in neuro-psychiatric diseases should continue to be defined. At the same time, clinicians are advised to pay attention to potentially detrimental immune suppression that may be associated with some of these medications, and consider iatrogenic etiology in patients presenting with undue susceptibility to infection.
Keywords: Inflammation, immune, psychotropic, psychopharmacology, psychiatric, immunodeficiency.
Current Psychopharmacology
Title:Immunologic Effects of Psychotropic Pharmaco-Therapeutics
Volume: 7
Author(s): Andrey Leonov*, Donald E. Greydanus and H.C. Athens
Affiliation:
- Western Michigan University, Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, MI 49008-1284,United States
Keywords: Inflammation, immune, psychotropic, psychopharmacology, psychiatric, immunodeficiency.
Abstract: Background: Common childhood neuropsychiatric disorders are treated with multiple categories of psycho-active agents. Adverse side effects of psychotropic pharmacotherapeutics range from expected neuro-psychiatric changes to allergic reactions and immunologic abnormalities.
Objective: This review focuses on the immune system effects of common categories of medications used to treat neuro-psychiatric and behavioral disorders.
Method: Narrative review of literature using PubMed database up to May 10, 2017.
Results: Multiple neuro- and psycho-tropic medication classes are found to influence the function of the immune system in various ways, both in the direction of immune suppression and immune stimulation.
Conclusion: Immunologic activity of these medications in the frame-work of now wellestablished role of inflammation in neuro-psychiatric diseases should continue to be defined. At the same time, clinicians are advised to pay attention to potentially detrimental immune suppression that may be associated with some of these medications, and consider iatrogenic etiology in patients presenting with undue susceptibility to infection.
Export Options
About this article
Cite this article as:
Leonov Andrey *, Greydanus E. Donald and Athens H.C. , Immunologic Effects of Psychotropic Pharmaco-Therapeutics, Current Psychopharmacology 2018; 7 (1) . https://dx.doi.org/10.2174/2211556006666171019155320
DOI https://dx.doi.org/10.2174/2211556006666171019155320 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In Vivo DNA Electrotransfer for Immunotherapy of Cancer and Neurodegenerative Diseases
Current Drug Metabolism Structural and Functional Organization of miRNAs
Current Pharmacogenomics Multitarget Drugs of Plants Origin Acting on Alzheimer's Disease
Current Medicinal Chemistry Aβ Produced as a Fusion to Maltose Binding Protein Can Be Readily Purified and Stably Associates with Copper and Zinc
Protein & Peptide Letters Glyceraldehyde-3-phosphate Dehydrogenase from Chironomidae Showed Differential Activity Towards Metals
Protein & Peptide Letters A Multi-layered Particulate System for Desvenlafaxine Succinate Oral Customized Release
Current Drug Delivery Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice
Current Alzheimer Research The Nutrigenetics and Pharmacogenetics of Vitamin D Pathways
Current Pharmacogenomics and Personalized Medicine Biomarkers of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), A Review of Published Patents and Patent Applications
Recent Patents on Biomarkers Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) CD133 Expressing Pericytes and Relationship to SDF-1 and CXCR4 in Spinal Cord Injury
Current Neurovascular Research Cyclophilin A: A Predictive Biomarker of Carotid Stenosis in Cerebral Ischemic Stroke
Current Neurovascular Research Meet Our Editorial Board Member:
Current Alzheimer Research Neuronal Plasticity, Stress and Depression: Involvement of the Cytoskeletal Microtubular System?
Current Drug Targets - CNS & Neurological Disorders Overview of the Metallometabolomic Methodology for Metal-Based Drug Metabolism
Current Drug Metabolism A Novel Prion Protein-Tyrosine Hydroxylase Interaction
CNS & Neurological Disorders - Drug Targets The Impact of Malnutrition on the Peripheral Serotoninergic System in Anorexia Nervosa: A Systematic Review
Current Psychiatry Reviews Cancer Chemopreventive Agents Discovered by Activity-Guided Fractionation: An Update
Current Organic Chemistry Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Perspectives and Challenges in Rational Exploitation of Phytochemicals in Cure, Control and Management of Diseases)
Current Pharmaceutical Design